Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 11/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1080648 | 1.00 | FDPS (0.39) | FDPSTSHRTHRBSMPD1ALDH1A1 | |
| Pentane SCHEMBL1913961 | 0.88 | TSHR (0.41) | FDPSTSHRTHRBALDH1A1 | |
| Hexane SCHEMBL3158631 | 0.86 | LMNA (0.37) | FDPSTSHRTHRBSMPD1GGPS1 | |
| SCHEMBL28475673 | 0.77 | TSHR (0.39) | FDPSTSHRTHRBSMPD1GGPS1 | |
| SCHEMBL7060348 | 0.76 | TSHR (0.40) | FDPSTSHRTHRBSMPD1ALDH1A1 | |
| Pentane SCHEMBL1914435 | 0.76 | LMNA (0.30) | TSHR | |
| SCHEMBL3048556 | 0.74 | TSHR (0.44) | FDPSTSHRTHRBSMPD1GGPS1 | |
| Chloroform SCHEMBL28494621 | 0.74 | FDPS (0.40) | FDPSSMPD1GGPS1 | |
| Hexane SCHEMBL4325387 | 0.73 | TSHR (0.58) | TSHRTHRBALDH1A1 | |
| Hexane SCHEMBL9244722 | 0.73 | TSHR (0.58) | TSHRTHRBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120225117-A1 | PROCESS FOR PRODUCTION OF W/O/W EMULSION, PROCESS FOR PRODUCTION OF LIPOSOME EMPLOYING THE PROCESS, AND POROUS MEMBRANE FOR USE IN THE PROCESSES | KONICA MINOLTA HOLDINGS, INC. (JP) | 2012-09-06 | — | — | US | disclosed |
| EP-2418191-A1 | Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same | Meiji Co., Ltd. (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-7893304-B2 | Hydroquinone long-chain derivatives and/or phenoxy long-chain derivatives, and pharmaceuticals comprising the same | MEIJI DAIRIES CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-20090036542-A1 | Hydroquinone Long-Chain Derivative and/or Phenoxy Long-Chain Derivative and Pharmaceutical Comprising Same | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2009-02-05 | — | — | US | disclosed |
| EP-1854777-A1 | HYDROQUINONE LONG-CHAIN DERIVATIVE AND/OR PHENOXY LONG-CHAIN DERIVATIVE, AND PHARMACEUTICAL PREPARATION COMPRISING THE SAME | Meiji Dairies Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036542-A1 | Hydroquinone Long-Chain Derivative and/or Phenoxy Long-Chain Derivative and Pharmaceutical Comprising Same | NQO1, NDUFA10, UQCRC1 | FDPS 4196/4885TSHR 3205/4885THRB 2106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.